Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Hartmann

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
Archives of Internal Medicine|July 27, 2005
Breast biopsy utilization: a population-based studyKarthik Ghosh, L Joseph Melton, Vera J Suman, et al.
Journal of the National Cancer Institute|March 13, 2008
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancerDaniel W Visscher, V Shane Pankratz, Marta Santisteban, et al.
Human Pathology|January 31, 2016
Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 casesAnnie L Meares, Ryan D Frank, Amy C Degnim, et al.
Journal of Nutrition Education and Behavior|May 7, 2008
Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companionsHeidi McKean, Sherry Looker, Lynn C Hartmann, et al.
Gynecologic Oncology|May 5, 2009
Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancerJeremy Chien, Jian-Bing Fan, Debra A Bell, et al.
Gynecologic Oncology|April 16, 2003
Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapyPrema P Peethambaram, William A Cliby, Gregory Lubiniecki, et al.
Breast Cancer Research and Treatment|February 11, 2014
Sclerosing adenosis and risk of breast cancerDaniel W Visscher, Aziza Nassar, Amy C Degnim, et al.
American Journal of Clinical Oncology|December 13, 2002
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literatureHarry J Long, Sandra Rayson, Karl C Podratz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancerKeith L Knutson, Christopher J Krco, Courtney L Erskine, et al.
Breast Cancer Research and Treatment|September 2, 2011
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissuesAmy C Degnim, Daniel W Visscher, Tanya L Hoskin, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Archives of Internal Medicine|July 27, 2005
Breast biopsy utilization: a population-based studyKarthik Ghosh, L Joseph Melton, Vera J Suman, et al.
Journal of the National Cancer Institute|March 13, 2008
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancerDaniel W Visscher, V Shane Pankratz, Marta Santisteban, et al.
Human Pathology|January 31, 2016
Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 casesAnnie L Meares, Ryan D Frank, Amy C Degnim, et al.
Journal of Nutrition Education and Behavior|May 7, 2008
Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companionsHeidi McKean, Sherry Looker, Lynn C Hartmann, et al.
Gynecologic Oncology|May 5, 2009
Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancerJeremy Chien, Jian-Bing Fan, Debra A Bell, et al.
Gynecologic Oncology|April 16, 2003
Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapyPrema P Peethambaram, William A Cliby, Gregory Lubiniecki, et al.
Breast Cancer Research and Treatment|February 11, 2014
Sclerosing adenosis and risk of breast cancerDaniel W Visscher, Aziza Nassar, Amy C Degnim, et al.
American Journal of Clinical Oncology|December 13, 2002
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literatureHarry J Long, Sandra Rayson, Karl C Podratz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancerKeith L Knutson, Christopher J Krco, Courtney L Erskine, et al.
Breast Cancer Research and Treatment|September 2, 2011
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissuesAmy C Degnim, Daniel W Visscher, Tanya L Hoskin, et al.
Pageof 15